期刊文献+

miR-363-3p在胃癌组织中的表达及其对细胞系HGC-27增殖、迁移与侵袭功能的影响 被引量:3

Expression of miR-363-3p in gastric cancer tissue and its effect on proliferation,migration and invasion of gastric cancer cell line HGC-27
下载PDF
导出
摘要 目的探讨miR-363-3p在胃癌及癌旁样本中的表达差异,并分析其在胃癌细胞系中的功能。方法使用realtime PCR检测59例胃癌组织及对应癌旁组织中miR-363-3p的表达差异;使用miR-363-3p模拟物(miR-363-3pmimic)实现miRNA在胃癌细胞系HGC-27中的过表达,经增殖实验、划痕实验和Transwell实验,检测miR-363-3p对HGC-27细胞功能的影响。结果 miR-363-3p抑制胃癌细胞系HGC-27细胞增殖(P<0.05,P<0.01),抑制胃癌细胞系HGC-27细胞迁移(P<0.001),miR-363-3p对抑制胃癌细胞系细胞的侵袭(P<0.05)。结论 miR-363-3p在胃癌发生中可能起到抑癌作用,并有可能成为对胃癌治疗的一个新靶点。 Objective To investigate of the expression of miR-363-3p in gastric cancer and its functional significance in HGC-27 cell line. Methods Real-time PCR analysis was used to detect the relative expression of miR- 363-3p in 59 pairs of gastric cancer tissues and their normal control tissues, miR-363-3p mimics was transfected into HGC-27 cell line for miR-363-3p overexpression. The effects of miR-363-3p overexpression on cell proliferation, migration and invasion were detected by CCK-8, wounding heal and Transwell assays. Results Overexpression of miR-363-3p was seen in gastric cancer cell line ( HGC-27 ). Proliferation text results showed that miR-363- 3p inhibited cell proliferation. Scratch test results showed that miR-363-3p inhibited cell migration. Transwell test results showed that miR-363-3p inhibited cell invasion. Conclusions miR-363-3p functions as a tumor suppressor miRNA in gastric cancer. Therefore it is a potential target for gastric cancer therapy.
出处 《基础医学与临床》 CSCD 2016年第5期638-643,共6页 Basic and Clinical Medicine
基金 国家自然科学基金重大研究计划(91440111) 国家自然科学基金(31371322)
关键词 胃癌 HGC-27 miR-363—3p gastric cancer HGC-27 miR-363-3p
  • 相关文献

参考文献10

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015,65:87-108.
  • 2Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer inci- dence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer,2015,136 : E359-386.
  • 3Ou Y,Zhai D,Wu N,et al. Downregulation of miR-363 in- creases drug resistance in cisplatin-treated HepG2 by dys- regulating Mcl- 1 [J]. Gene,2015,572 : 116-122.
  • 4Jamali Z, Asl Aminabadi N, Attaran R,et al. MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-a- nalysis [J]. Oral Onco1,2015,51 : 321 - 331.
  • 5Chapman BV,Wald AI,Akhtar P,et al. MicroRNA-363 tar- gets myosin 1B to reduce cellular migration in head and neck cancer[J]. BMC Cancer ,2015,15:861-870.
  • 6Li Y,Chen D,Li Y,et al. Oncogenie cAMP responsive ele- ment binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-Sp and miR-363-3p in renal cancer [J]. Oncol Rep,2016,35 : 1967-1978.
  • 7Cong D, He M, Chen S, et al. Expression profiles of pivot- al microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas[J]. Onco Targets T- her, 2015,26 : 2271 - 2277.
  • 8Tsuji S, Kawasaki Y, Furukawa S,et al. The miR- 363- GA- TA6-Lgr5 pathway is critical for colorectal tumourigenesis [J]. Nat Commun,2014,5:3150-3161.
  • 9Mosakhani N,Raty R,Tyybakinoja A et al. MicroRNA pro- filing in chemoresistant and chemosensitive acute myeloid leukemia[J]. Cytogenet Genome Res,2013,141:272-276.
  • 10Coskun E,Neumann M,Schlee C,et al. MicroRNA profi- ling reveals aberrant microRNA expression in adult ETP- ALL and functional studies implicate a role for miR-222 in acute leukemia[J]. Leuk Res,2013 ,37 :647-656.

同被引文献15

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部